• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

脂肪肝、胰岛素抵抗和代谢综合征特征:与 10153 人的冠状动脉钙的关系。

Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.

机构信息

Division of Cardiology, Department of Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

出版信息

Diabetes Care. 2012 Nov;35(11):2359-64. doi: 10.2337/dc12-0515. Epub 2012 Jul 24.

DOI:10.2337/dc12-0515
PMID:22829522
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3476919/
Abstract

OBJECTIVE

Nonalcoholic fatty liver disease (NAFLD) coexists with insulin resistance (IR), but it is uncertain whether NAFLD and IR contribute independently to atherosclerosis. We tested whether fatty liver, IR, and metabolic syndrome (MetS) features (waist, glucose, triglyceride, HDL cholesterol [HDL-C], and blood pressure) were associated with a marker of atherosclerosis (coronary artery calcium [CAC] score >0), independently of cardiovascular risk factors and cardiovascular disease (CVD).

RESEARCH DESIGN AND METHODS

Data were analyzed from a South Korean occupational cohort of 10,153 people who all received ultrasound measurements of fatty liver and a cardiac computed tomography CAC score. IR was defined by homeostasis model assessment of IR (HOMA-IR) ≥75th percentile. Odds ratios (ORs) (95% CIs) for the presence of a CAC score >0 were estimated using logistic regression.

RESULTS

There were 915 people with a CAC score >0. MetS features were increased (glucose, blood pressure, triglyceride, and waist) or decreased (HDL-C) among people with a CAC score >0 (all comparisons against CAC score ≤0; P < 0.0001). Of subjects with a CAC score >0, 55% had fatty liver and 33.7% were insulin resistant. Fatty liver (OR 1.21 [95% CI 1.01-1.45]; P = 0.04) and HOMA-IR (1.10 [1.02-1.18]; P = 0.02) were associated with CAC score >0, independently of all MetS features, conventional cardiovascular risk factors, and prior evidence of CVD. The presence of IR and fatty liver combined was associated with CAC score >0 (1.53 [1.20-1.95]; P = 0.001).

CONCLUSIONS

Fatty liver and HOMA-IR are both associated with a CAC score >0 (independently of each other), features of MetS, conventional cardiovascular risk factors, and existing CVD.

摘要

目的

非酒精性脂肪性肝病(NAFLD)与胰岛素抵抗(IR)并存,但尚不确定 NAFLD 和 IR 是否独立促进动脉粥样硬化。我们检测了脂肪肝、IR 和代谢综合征(MetS)特征(腰围、血糖、甘油三酯、高密度脂蛋白胆固醇 [HDL-C] 和血压)与动脉粥样硬化标志物(冠状动脉钙 [CAC] 评分 >0)的相关性,是否独立于心血管危险因素和心血管疾病(CVD)。

研究设计和方法

对韩国职业队列的 10153 名参与者进行了数据分析,这些人都接受了脂肪肝超声检查和心脏计算机断层扫描 CAC 评分检查。IR 通过稳态模型评估的胰岛素抵抗(HOMA-IR)≥75 百分位数来定义。使用逻辑回归估计 CAC 评分 >0 的存在的比值比(OR)(95%CI)。

结果

共有 915 人 CAC 评分 >0。CAC 评分 >0 的人群中 MetS 特征增加(血糖、血压、甘油三酯和腰围)或降低(HDL-C)(与 CAC 评分 ≤0 的所有比较;均 P <0.0001)。在 CAC 评分 >0 的人群中,55%有脂肪肝,33.7%有胰岛素抵抗。脂肪肝(OR 1.21 [95%CI 1.01-1.45];P = 0.04)和 HOMA-IR(1.10 [1.02-1.18];P = 0.02)与 CAC 评分 >0 独立相关,独立于所有 MetS 特征、传统心血管危险因素和先前 CVD 的证据。IR 和脂肪肝的同时存在与 CAC 评分 >0 相关(1.53 [1.20-1.95];P = 0.001)。

结论

脂肪肝和 HOMA-IR 均与 CAC 评分 >0 相关(相互独立),与 MetS 特征、传统心血管危险因素和现有的 CVD 相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/3476919/9cc24788946d/2359fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/3476919/9cc24788946d/2359fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/32c5/3476919/9cc24788946d/2359fig1.jpg

相似文献

1
Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people.脂肪肝、胰岛素抵抗和代谢综合征特征:与 10153 人的冠状动脉钙的关系。
Diabetes Care. 2012 Nov;35(11):2359-64. doi: 10.2337/dc12-0515. Epub 2012 Jul 24.
2
Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.脂肪肝、胰岛素抵抗与肥胖:随时间推移与冠状动脉钙化增加的关系。
Clin Cardiol. 2016 Jun;39(6):321-8. doi: 10.1002/clc.22529. Epub 2016 Mar 21.
3
Lipoprotein (a), metabolic syndrome and coronary calcium score in a large occupational cohort.脂蛋白 (a)、代谢综合征与大型职业队列的冠状动脉钙评分。
Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1239-46. doi: 10.1016/j.numecd.2013.02.009. Epub 2013 Jun 17.
4
Association of Non-alcoholic Fatty Liver Disease with Metabolic Syndrome Independently of Central Obesity and Insulin Resistance.非酒精性脂肪性肝病与代谢综合征的关联独立于中心性肥胖和胰岛素抵抗。
Sci Rep. 2016 Jun 1;6:27034. doi: 10.1038/srep27034.
5
Insulin resistance, metabolic syndrome, and subclinical atherosclerosis: the Multi-Ethnic Study of Atherosclerosis (MESA).胰岛素抵抗、代谢综合征与亚临床动脉粥样硬化:动脉粥样硬化多民族研究(MESA)
Diabetes Care. 2007 Nov;30(11):2951-6. doi: 10.2337/dc07-1042. Epub 2007 Aug 17.
6
The impact of non-alcoholic fatty liver disease and metabolic syndrome on the progression of coronary artery calcification.非酒精性脂肪肝疾病和代谢综合征对冠状动脉钙化进展的影响。
Sci Rep. 2018 Aug 13;8(1):12004. doi: 10.1038/s41598-018-30465-y.
7
Metabolically healthy obese subjects are at risk of fatty liver but not of pre-clinical atherosclerosis.代谢健康的肥胖受试者有患脂肪肝的风险,但没有临床前期动脉粥样硬化的风险。
Nutr Metab Cardiovasc Dis. 2014 Mar;24(3):256-62. doi: 10.1016/j.numecd.2013.07.005. Epub 2013 Oct 9.
8
Relationship between a novel non-insulin-based metabolic score for insulin resistance (METS-IR) and coronary artery calcification.新型非胰岛素相关的胰岛素抵抗代谢评分(METS-IR)与冠状动脉钙化的关系。
BMC Endocr Disord. 2022 Nov 10;22(1):274. doi: 10.1186/s12902-022-01180-7.
9
Alcoholic and non-alcoholic fatty liver disease and associations with coronary artery calcification: evidence from the Kangbuk Samsung Health Study.酒精性和非酒精性脂肪性肝病与冠状动脉钙化的关系:来自康伯三星健康研究的证据。
Gut. 2019 Sep;68(9):1667-1675. doi: 10.1136/gutjnl-2018-317666. Epub 2018 Nov 24.
10
Controlling for apolipoprotein A-I concentrations changes the inverse direction of the relationship between high HDL-C concentration and a measure of pre-clinical atherosclerosis.校正载脂蛋白 A-I 浓度后,改变了高 HDL-C 浓度与临床前动脉粥样硬化指标之间的反向关系。
Atherosclerosis. 2013 Dec;231(2):181-6. doi: 10.1016/j.atherosclerosis.2013.09.009. Epub 2013 Sep 25.

引用本文的文献

1
Association of Estimated Glucose Disposal Rate With Risk of Abdominal Aortic Aneurysm: Evidence From a Large-Scale Prospective Cohort Study of the UK Biobank.估计葡萄糖处置率与腹主动脉瘤风险的关联:来自英国生物银行大规模前瞻性队列研究的证据
Rev Cardiovasc Med. 2025 Jul 21;26(7):36776. doi: 10.31083/RCM36776. eCollection 2025 Jul.
2
A plasma metabolomic analysis revealed the metabolic regulatory mechanism of the water extract of Dendrobium huoshanense in improving streptozotocin-induced type 1 diabetes model rats.一项血浆代谢组学分析揭示了霍山石斛水提取物改善链脲佐菌素诱导的1型糖尿病模型大鼠的代谢调控机制。
J Nat Med. 2025 May 20. doi: 10.1007/s11418-025-01909-3.
3

本文引用的文献

1
Non-alcoholic fatty liver disease: a new and important cardiovascular risk factor?非酒精性脂肪性肝病:一个新的重要心血管风险因素?
Eur Heart J. 2012 May;33(10):1190-200. doi: 10.1093/eurheartj/ehr453. Epub 2012 Mar 8.
2
Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.胰岛素抵抗、超重/肥胖和脂肪肝联合作用作为 2 型糖尿病的危险因素。
Diabetes Care. 2012 Apr;35(4):717-22. doi: 10.2337/dc11-1853. Epub 2012 Feb 14.
3
Nonalcoholic fatty liver disease is associated with coronary artery calcification.
The Paradox of Physical Activity and Coronary Artery Calcification: Implications for Cardiovascular Risk.
体力活动与冠状动脉钙化的悖论:对心血管风险的影响
J Clin Med. 2024 Oct 30;13(21):6523. doi: 10.3390/jcm13216523.
4
Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: A Bidirectional Association Based on Endothelial Dysfunction.非酒精性脂肪性肝病与冠状动脉疾病:基于血管内皮功能障碍的双向关联。
Int J Mol Sci. 2024 Oct 1;25(19):10595. doi: 10.3390/ijms251910595.
5
Association of triglyceride-glucose index with the risk of incident aortic dissection and aneurysm: a large-scale prospective cohort study in UK Biobank.甘油三酯-葡萄糖指数与主动脉夹层和动脉瘤发病风险的关联:英国生物库中一项大规模前瞻性队列研究。
Cardiovasc Diabetol. 2024 Aug 2;23(1):282. doi: 10.1186/s12933-024-02385-x.
6
Cardiovascular risk, fatty liver disease, glucose and insulin curve among prediabetes phenotypes in Peruvian population.秘鲁人群中糖尿病前期表型的心血管风险、脂肪肝疾病、血糖和胰岛素曲线
Am J Med Open. 2022 Feb 2;7:100007. doi: 10.1016/j.ajmo.2022.100007. eCollection 2022 Jun.
7
Influence of nonalcoholic fatty liver disease severity on carotid adventitial vasa vasorum.非酒精性脂肪性肝病严重程度对颈动脉外膜血管腔的影响。
Front Endocrinol (Lausanne). 2024 May 7;15:1366015. doi: 10.3389/fendo.2024.1366015. eCollection 2024.
8
Triglyceride-glucose index is an independent predictor of coronary artery calcification progression in patients with chronic kidney disease.甘油三酯-葡萄糖指数是慢性肾脏病患者冠状动脉钙化进展的独立预测因子。
Kidney Res Clin Pract. 2024 May;43(3):381-390. doi: 10.23876/j.krcp.23.264. Epub 2024 Mar 18.
9
Genetic Variants Linked to Myocardial Infarction in Individuals with Non-Alcoholic Fatty Liver Disease and Their Potential Interaction with Dietary Patterns.与非酒精性脂肪性肝病患者心肌梗死相关的遗传变异及其与饮食模式的潜在相互作用。
Nutrients. 2024 Feb 22;16(5):602. doi: 10.3390/nu16050602.
10
Non-alcoholic fatty liver disease biomarkers estimate cardiovascular risk based on coronary artery calcium score in type 2 diabetes: a cross-sectional study with two independent cohorts.非酒精性脂肪性肝病生物标志物基于冠状动脉钙评分估计 2 型糖尿病患者的心血管风险:两项独立队列的横断面研究。
Cardiovasc Diabetol. 2024 Feb 13;23(1):69. doi: 10.1186/s12933-024-02161-x.
非酒精性脂肪肝疾病与冠状动脉钙化有关。
Hepatology. 2012 Aug;56(2):605-13. doi: 10.1002/hep.25593. Epub 2012 Jul 2.
4
Roles of PPARs in NAFLD: potential therapeutic targets.过氧化物酶体增殖物激活受体在非酒精性脂肪性肝病中的作用:潜在的治疗靶点。
Biochim Biophys Acta. 2012 May;1821(5):809-18. doi: 10.1016/j.bbalip.2011.10.016. Epub 2011 Oct 25.
5
Visceral abdominal adipose tissue and coronary atherosclerosis in asymptomatic diabetics.无症状糖尿病患者内脏腹部脂肪组织与冠状动脉粥样硬化。
Int J Cardiol. 2013 Jan 20;162(3):184-8. doi: 10.1016/j.ijcard.2011.05.059. Epub 2011 Jun 8.
6
The relationship between insulin resistance and incidence and progression of coronary artery calcification: the Multi-Ethnic Study of Atherosclerosis (MESA).胰岛素抵抗与冠状动脉钙化的发生和进展的关系:动脉粥样硬化的多民族研究(MESA)。
Diabetes Care. 2011 Mar;34(3):749-51. doi: 10.2337/dc10-1681. Epub 2011 Feb 3.
7
Relationship of hepatic steatosis and alanine aminotransferase with coronary calcification.肝脂肪变性和丙氨酸氨基转移酶与冠状动脉钙化的关系。
Clin Chem Lab Med. 2010 Dec;48(12):1829-34. doi: 10.1515/CCLM.2010.349. Epub 2010 Oct 20.
8
Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的心血管疾病风险
N Engl J Med. 2010 Sep 30;363(14):1341-50. doi: 10.1056/NEJMra0912063.
9
Presence of coronary plaques in patients with nonalcoholic fatty liver disease.非酒精性脂肪性肝病患者的冠状动脉斑块存在。
Radiology. 2010 Feb;254(2):393-400. doi: 10.1148/radiol.09090769.
10
Decreased survival of subjects with elevated liver function tests during a 28-year follow-up.在 28 年的随访中,肝功能检查升高的受试者生存率降低。
Hepatology. 2010 Feb;51(2):595-602. doi: 10.1002/hep.23314.